Category: Disorders & Diseases

Disorders & Diseases

FDA Approves Orzeyful for Narcolepsy Type 1

Orzeyful is the first drug to target the underlying loss of orexin signaling to address the full range of narcolepsy type 1.

Disorders & Diseases

Invasive Mold Disease Tied to High ICU and Ventilation Rates

Half of patients with invasive mold infections require mechanical ventilation, with significantly higher mortality observed in those with recent COVID-19.

Disorders & Diseases

Lung Cancer Survival Rates ‘Improving for Everyone,’ National Report Reveals

The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.

Chronic Pulmonary Disorders

Rapid Test for COPD Exacerbations Begins Study

ProAxsis and Imperial College London are investigating the NEATstik test, which detects active neutrophil elastase (NE) in sputum samples.

Infectious Diseases

Intelligenome, Cornell Partner on Portable TB Diagnostic

The collaboration will focus on a point-of-care testing platform designed to detect tuberculosis from respiratory and blood samples.

Critical Care

PCV-VG Ventilation Mode Improved Lung Mechanics

Pressure control-volume guarantee (PCV-VG) ventilation improved intraoperative respiratory mechanics but did not significantly reduce postoperative pulmonary complications compared with conventional volume control ventilation in patients undergoing emergency abdominal surgery.

Cardiopulmonary & Thoracic

Stand Up To Cancer Funds Research for Early Lung Cancer Detection

Three research teams are developing noninvasive, cost-effective screening tools to improve lung cancer detection rates among smokers and non-smokers.

Sleep Medicine

FDA Clears HoneyNaps Ai Software for Sleep Apnea Analysis

The USFDA granted 510(k) clearance for the HoneyNaps Somnum V3.0 Ai-based software for polysomnography (PSG) analysis, according to the company.